176 related articles for article (PubMed ID: 36376887)
1. Efficacy and pharmacokinetics of betaine in CBS and cblC deficiencies: a cross-over randomized controlled trial.
Imbard A; Toumazi A; Magréault S; Garcia-Segarra N; Schlemmer D; Kaguelidou F; Perronneau I; Haignere J; de Baulny HO; Kuster A; Feillet F; Alberti C; Guilmin-Crépon S; Benoist JF; Schiff M
Orphanet J Rare Dis; 2022 Nov; 17(1):417. PubMed ID: 36376887
[TBL] [Abstract][Full Text] [Related]
2. Homocystinuria due to cystathionine beta-synthase deficiency--the effects of betaine treatment in pyridoxine-responsive patients.
Wilcken DE; Dudman NP; Tyrrell PA
Metabolism; 1985 Dec; 34(12):1115-21. PubMed ID: 3934499
[TBL] [Abstract][Full Text] [Related]
3. Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.
Maclean KN; Jiang H; Greiner LS; Allen RH; Stabler SP
Mol Genet Metab; 2012 Mar; 105(3):395-403. PubMed ID: 22192524
[TBL] [Abstract][Full Text] [Related]
4. Homocystinuria--the effects of betaine in the treatment of patients not responsive to pyridoxine.
Wilcken DE; Wilcken B; Dudman NP; Tyrrell PA
N Engl J Med; 1983 Aug; 309(8):448-53. PubMed ID: 6877313
[TBL] [Abstract][Full Text] [Related]
5. Laboratory evaluation of homocysteine remethylation disorders and classic homocystinuria: Long-term follow-up using a cohort of 123 patients.
De Biase I; Gherasim C; La'ulu SL; Asamoah A; Longo N; Yuzyuk T
Clin Chim Acta; 2020 Oct; 509():126-134. PubMed ID: 32533987
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of betaine-homocysteine S-methyltransferase in rats causes hyperhomocysteinemia and reduces liver cystathionine β-synthase activity and methylation capacity.
Strakova J; Gupta S; Kruger WD; Dilger RN; Tryon K; Li L; Garrow TA
Nutr Res; 2011 Jul; 31(7):563-71. PubMed ID: 21840473
[TBL] [Abstract][Full Text] [Related]
7. Human homocysteine catabolism: three major pathways and their relevance to development of arterial occlusive disease.
Dudman NP; Guo XW; Gordon RB; Dawson PA; Wilcken DE
J Nutr; 1996 Apr; 126(4 Suppl):1295S-300S. PubMed ID: 8642474
[TBL] [Abstract][Full Text] [Related]
8. Betaine supplementation is less effective than methionine restriction in correcting phenotypes of CBS deficient mice.
Gupta S; Wang L; Kruger WD
J Inherit Metab Dis; 2016 Jan; 39(1):39-46. PubMed ID: 26231230
[TBL] [Abstract][Full Text] [Related]
9. Taurine alleviates repression of betaine-homocysteine
Maclean KN; Jiang H; Phinney WN; Keating AK; Hurt KJ; Stabler SP
FASEB J; 2019 May; 33(5):6339-6353. PubMed ID: 30768359
[TBL] [Abstract][Full Text] [Related]
10. Effects of betaine in a murine model of mild cystathionine-beta-synthase deficiency.
Schwahn BC; Wendel U; Lussier-Cacan S; Mar MH; Zeisel SH; Leclerc D; Castro C; Garrow TA; Rozen R
Metabolism; 2004 May; 53(5):594-9. PubMed ID: 15131763
[TBL] [Abstract][Full Text] [Related]
11. Interplay of Enzyme Therapy and Dietary Management of Murine Homocystinuria.
Park I; Bublil EM; Glavin F; Majtan T
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32971905
[TBL] [Abstract][Full Text] [Related]
12. Cystathionine beta-synthase deficiency: effects of betaine supplementation after methionine restriction in B6-nonresponsive homocystinuria.
Singh RH; Kruger WD; Wang L; Pasquali M; Elsas LJ
Genet Med; 2004; 6(2):90-5. PubMed ID: 15017331
[TBL] [Abstract][Full Text] [Related]
13. Elevated dimethylglycine in blood of children with congenital heart defects and their mothers.
Alsayed R; Al Quobaili F; Srour S; Geisel J; Obeid R
Metabolism; 2013 Aug; 62(8):1074-80. PubMed ID: 23481916
[TBL] [Abstract][Full Text] [Related]
14. Treatment of inherited homocystinurias.
Schiff M; Blom HJ
Neuropediatrics; 2012 Dec; 43(6):295-304. PubMed ID: 23124942
[TBL] [Abstract][Full Text] [Related]
15. [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].
Guilland JC; Favier A; Potier de Courcy G; Galan P; Hercberg S
Pathol Biol (Paris); 2003 Mar; 51(2):101-10. PubMed ID: 12801808
[TBL] [Abstract][Full Text] [Related]
16. High homocysteine induces betaine depletion.
Imbard A; Benoist JF; Esse R; Gupta S; Lebon S; de Vriese AS; de Baulny HO; Kruger W; Schiff M; Blom HJ
Biosci Rep; 2015 Apr; 35(4):. PubMed ID: 26182429
[TBL] [Abstract][Full Text] [Related]
17. Methionine transamination in patients with homocystinuria due to cystathionine beta-synthase deficiency.
Tangerman A; Wilcken B; Levy HL; Boers GH; Mudd SH
Metabolism; 2000 Aug; 49(8):1071-7. PubMed ID: 10954028
[TBL] [Abstract][Full Text] [Related]
18. An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria.
Matthews A; Johnson TN; Rostami-Hodjegan A; Chakrapani A; Wraith JE; Moat SJ; Bonham JR; Tucker GT
Br J Clin Pharmacol; 2002 Aug; 54(2):140-6. PubMed ID: 12207633
[TBL] [Abstract][Full Text] [Related]
19. Consideration of betaine and one-carbon sources of N5-methyltetrahydrofolate for use in homocystinuria and neural tube defects.
Benevenga NJ
Am J Clin Nutr; 2007 Apr; 85(4):946-9. PubMed ID: 17413090
[TBL] [Abstract][Full Text] [Related]
20. Free and protein-bound homocysteine and cysteine in cystathionine beta-synthase deficiency: interrelations during short- and long-term changes in plasma concentrations.
Wiley VC; Dudman NP; Wilcken DE
Metabolism; 1989 Aug; 38(8):734-9. PubMed ID: 2761410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
